232 related articles for article (PubMed ID: 11709317)
1. MDR1-mediated drug resistance in Candida dubliniensis.
Wirsching S; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
Antimicrob Agents Chemother; 2001 Dec; 45(12):3416-21. PubMed ID: 11709317
[TBL] [Abstract][Full Text] [Related]
2. Isogenic strain construction and gene targeting in Candida dubliniensis.
Staib P; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
J Bacteriol; 2001 May; 183(9):2859-65. PubMed ID: 11292806
[TBL] [Abstract][Full Text] [Related]
3. Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate.
Hiller D; Stahl S; Morschhäuser J
Antimicrob Agents Chemother; 2006 Jul; 50(7):2300-8. PubMed ID: 16801405
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans.
Hiller D; Sanglard D; Morschhäuser J
Antimicrob Agents Chemother; 2006 Apr; 50(4):1365-71. PubMed ID: 16569853
[TBL] [Abstract][Full Text] [Related]
5. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
Moran GP; Sanglard D; Donnelly SM; Shanley DB; Sullivan DJ; Coleman DC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1819-30. PubMed ID: 9661028
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.
Schubert S; Rogers PD; Morschhäuser J
Antimicrob Agents Chemother; 2008 Dec; 52(12):4274-80. PubMed ID: 18809934
[TBL] [Abstract][Full Text] [Related]
7. The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.
Moran G; Sullivan D; Morschhäuser J; Coleman D
Antimicrob Agents Chemother; 2002 Sep; 46(9):2829-41. PubMed ID: 12183235
[TBL] [Abstract][Full Text] [Related]
8. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
9. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
[TBL] [Abstract][Full Text] [Related]
10. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
11. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.
Wirsching S; Michel S; Morschhäuser J
Mol Microbiol; 2000 May; 36(4):856-65. PubMed ID: 10844673
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance genes and trailing growth in Candida albicans isolates.
Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
[TBL] [Abstract][Full Text] [Related]
13. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Perea S; López-Ribot JL; Wickes BL; Kirkpatrick WR; Dib OP; Bachmann SP; Keller SM; Martinez M; Patterson TF
Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.
Morschhäuser J; Barker KS; Liu TT; BlaB-Warmuth J; Homayouni R; Rogers PD
PLoS Pathog; 2007 Nov; 3(11):e164. PubMed ID: 17983269
[TBL] [Abstract][Full Text] [Related]
16. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
[TBL] [Abstract][Full Text] [Related]
17. The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans.
Alarco AM; Raymond M
J Bacteriol; 1999 Feb; 181(3):700-8. PubMed ID: 9922230
[TBL] [Abstract][Full Text] [Related]
18. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
[TBL] [Abstract][Full Text] [Related]
19. CARE-2 fingerprinting of Candida albicans isolates.
Morschhäuser J; Staib P; Köhler G
Methods Mol Med; 2005; 118():27-34. PubMed ID: 15888932
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
